- European Central Banks Expected to Slash Rates
- Euro Stocks Rebound; Rate Cuts Expected
- MGA Ordered to Stop Selling Bratz Dolls
- Euro Stocks to Open Flat before Rate Decisions
- Nomura to Cut Up to 1,000 Positions in London
- Capital One to Purchase Chevy Chase
- Australia Economy Injured as Vehicle Sales Crash
- Japan Faces Deep Recession, Central Banks Cut Rates
- Banks Throw Babcock & Brown a Lifeline
- Lightning Round: Microsoft, Motorola, NYSE and More
- Lightning Round OT: Hertz, Textron and More
- Mad Mail: Cramer's Plan for the SEC
- The Plaxico Burress Good Judgment Award
- Cramer's Call on Celgene
- Your First Move For Thursday December 4th
- Web Extra: Fast & Furious Trades For Thursday
- Cramer's M&A Plays
- Retailers Move Market?
Text Size 
As the Dow Jones Industrial Average soared Tuesday to close 270 points higher, CNBC asked market experts for their best investment advice.
Building Profits
“[Lennar] [LEN
Loading...
()
] had gotten unusually cheap, given they were focused more on being a merchant builder and moving away from having bigger land positions. We thought it made sense and the stock responded pretty favorably.”
- David Goldberg, UBS analyst
'Dynamic Growth Drivers'
A deal for Roche to buy the remaining shares of Genentech [DNA
Loading...
()
] "might not get done due to liquidity issues right now. Even if it doesn’t, they’ve got several dynamic growth drivers in cancer. It’s a company that makes money so there’s great cash flow.”
- Michael Cuggino, Permanent Portfolio Funds portfolio manager
Cuggino also likes State Street [STT
Loading...
()
] and Chevron [CVX
Loading...
()
].
More Investment Advice on CNBC.com
Print
Email
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes